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Dietary  immunomodulators  can  help  to  defend  against  disease,  but their  dosage  and  time  of
administration  are  not  always  clear  in aquaculture.  In  this  study,  we  analyzed  the  amount
of dietary  levamisole  required  to induce  an  adjuvant  effect.  Because  immunostimulants
and  immunization  can  improve  the  ﬁsh  immune  system,  this  study  evaluated  the effects
of  dietary  levamisole  administration  (at  0, 125,  250 and 500  mg/kg  diet) and  immunization
with  A. hydrophila  (1 ×  109 CFU)  on the  acquired  and  innate  immune  systems  of pacu  (mean
initial  weight  176.03  ± 15.73  g). The  results  showed  that levamisole  can  act  as  an  adjuvant
for  vaccination,  even  when  administered  through  the diet.  Immunization  and  levamisole
administration  increased  the  antibody  titer,  serum  bactericidal  activity,  and  hematocrit  as
well  as the numbers  of  red blood  cells,  leukocytes  and  thrombocytes  in  pacu  (P <  0.05).
However,  the  lysozyme  activity;  leukocyte  respiratory  activity;  total  protein,  albumin,
and globulin  levels;  A:G  index;  corpuscular  hemoglobin  volume;  and  other  white  blood
cells  showed  no differences  when  compared  with  the  control  ﬁsh.  As  the  immunostim-
ulant  improved,  certain  parameters  of the acquired  and  innate  immune  systems  of pacu
increased,  and the  administration  of  levamisole  in  the diet  (125  or 250  mg/kg)  for  seven
days  may  be  used  to promote  adjuvant  effects  during  immunization  with  A.  hydrophila  and
thus  constitutes  a feed  protocol  strategy  to be used  prior  to  immunization.
©  2015  Elsevier  B.V.  All  rights  reserved.
1. IntroductionThe aquaculture industry in Brazil has been growing since the late 1980s, and many ﬁsh species are being farmed.
However, this intensiﬁcation has led to disease outbreaks. Because the use of antibiotics has been widely criticized during
the past decade due to its negative impacts on the environment as well as on ﬁsh, dietary immunostimulants are being
used as an alternative treatment. Immunostimulants can overcome several problems caused by the misuse of antibiotics,
Abbreviations: MHC, major histocompatibility complex; CFU, colony-forming unit; CP, crude protein; TSA, trypticase soy agar; PBS, phosphate-buffered
saline; NBT, nitroblue tetrazolium; DMF, dimethylformamide; A:G, albumin:globulin; DE, digestible energy; SEM, standard error of the means; ROS, reactive
oxygen species; HSI, hepatosomatic index; MCV, mean corpuscular value; SGC, special granulocyte cell.
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uch as the accumulation of these drugs in the environment and the development of bacterial resistance and immune
uppression (Sakai, 1999; Tort, 2011; Kiron, 2012; Baba et al., 2014). Nonetheless, there is a lack of information about the
reatment period, dose and administration route for immunostimulants in several species of ﬁsh (Mulero et al., 1998; Sink
nd Lochmann, 2014).
The responses of the ﬁsh immune system can be modulated by certain substances, such as levamisole, a synthetic
nthelmintic used in mammals that is also a strong trigger of innate and speciﬁc immunity in ﬁsh (Reverter et al., 2014;
iwicki, 1987). In fact, levamisole is considered to be an adjuvant compound upon vaccination because it improves the
ntensity of the immune response, although this immunostimulant is commonly administered via injection. Adjuvants are
onsidered to enhance antigen-speciﬁc immune responses because they result in increased antibody titers. Levamisole is
 T-independent antigen that prompts an acquired response based on its ability to modulate natural killer cells during cell
ysis induction, MHC  receptor expression and cytokine increases, including IFN- and IL-6 (Holcombe et al., 2006; Kang
t al., 2005).
Furthermore, this immunostimulant promotes improvements in innate parameters such as the cytotoxic activity of
eukocytes (Cheng et al., 2008; Fierro-Castro et al., 2012), phagocytosis (Mulero et al., 1998; Findlay and Munday, 2000),
nd the respiratory activity of macrophages (Siwicki, 1989; Mulero et al., 1998). Levamisole also improves speciﬁc immune
esponses (Jeney and Anderson, 1993; Cuesta et al., 2004) and elicits increased resistance against various etiological agents,
ncluding Vibrio anguillarum (Kajita et al., 1990), Aeromonas hydropila (Baba et al., 1993), Paramoeba spp. (Findlay et al., 2000;
unday and Zilberg, 2003), Edwardsiella tarda (Sahoo and Mukherjee, 2002), Photobacterium damselae (Leano et al., 2003),
nd the nematode Anguillicola crassus (Geets et al., 1992).
The use of dietary immunostimulants is a viable approach to preventing the economic losses caused by disease outbreaks,
uch as infection by A. hydrophila,a gram-negative bacterium that is widely distributed in aquatic environments that has
 negative economic impact on aquaculture worldwide (Austin and Austin, 1999; Janda and Abbott, 1998). However, few
tudies have been conducted to evaluate the immune system of Brazilian ﬁsh, and additional research into immune modu-
ation is needed. Pacu, or Piaractus mesopotamicus, is a remarkable native ﬁsh with great economic importance because of
ts production characteristics, such as its rustic management, rapid growth rate and consumer acceptance (Takahashi et al.,
006; Castro et al., 2014). The present study was designed to explore the effects of dietary levamisole on the innate and
daptive immunity as well as the biochemical and hematological parameters of P. mesopotamicus.
. Materials and methods
.1. Animals and installations
A total of 240 pacu (176.03 ± 15.73 g; 20.29 ± 1.17 cm)  were distributed among 24 100 L tanks (10 ﬁsh per tank, 6 replicate
anks for each treatment) and allowed to acclimatize for 20 days prior to experimental feeding; during this time, the ﬁsh
ere fed twice per day to apparent satiation with a commercial diet (28% crude protein, 3% fat, 1% ﬁber, levamisole-free).
his study was approved by the Ethics Committee on animal use of the Universidade Estadual Paulista “Julio de Mesquita
ilho” UNESP (protocol number 004206/10). A photoperiod of 12 h light:12 h dark (07.00-19.00 h) was  used. The experiment
as performed indoors in tanks that were supplied with a constant ﬂux of water of 2-2.5 L per min. The culture system was
lso provided with continuous aeration by an air compressor. The tanks were cleaned of feces and uneaten feed every two
ays via aspiration. The water temperature, dissolved oxygen and pH were monitored daily using a YSI 55 Oxygen Meter
Yellow Spring Instrument, Yellow Spring, OH, USA) and a YSI 63 pH Meter (Yellow Springs Instrument, Yellow Springs,
H, USA), respectively. Total ammonia nitrogen was  monitored every week (Nessler reagent). The values stayed within the
ppropriate ranges described for this species (Urbinati et al., 2010) as follows: temperature 27.86 ± 0.83 ◦C, dissolved oxygen
.61 ± 0.66 mg/L, pH 7.57 ± 0.34 and NH4 0.25 ± 0.15 mg/L.
.2. Experimental diets
The diet that was used for ﬁsh acclimatization and as the base for the levamisole-containing food was  a commercial diet
ontaining 28% crude protein and an estimated digestible energy level of 12.56 MJ/kg (FRI-RIBE, Sao Paulo, Brazil). Levamisole
SIGMA, St. Louis, MO,  USA) was added to the commercial diet at 0, 125, 250 or 500 mg/kg. During the conditioning and
xperimental periods, the ﬁsh were fed two daily meals until apparent satiety.
.3. Feeding trials and experimental design
The experiment was divided in two trials, with the ﬁrst feeding trial performed to evaluate the optimal doses and
uration of levamisole administration and to determine the adjuvant effects of the drug on non-speciﬁc immune responses
nd the hematological and serum biochemistry parameters of pacu. In the ﬁrst trial, the ﬁsh were randomly divided into
ight treatments in a factorial design with two periods (seven and 15 days) and four levamisole levels (0, 125, 250 and
00 mg/kg); there were six replicates for each treatment. The experimental diets were offered to the ﬁsh in two daily meals
or seven or 15 days.
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The second feeding trial was conducted to evaluate the adjuvant effects of levamisole after immunization against A.
hydrophila on the speciﬁc and nonspeciﬁc immune responses and hematological and biochemical parameters of pacu. The
ﬁsh were given experimental diets for seven days because that was the shortest time (found in Trial 1) to elicit an effect.
The ﬁsh were randomly divided into eight treatment groups consisting of two  sampling times (before and after inactive A.
hydrophilainoculation) and four levels of dietary levamisole (0, 125, 250 and 500 mg/kg), with six replicates per treatment.
The experimental diets were offered to the ﬁsh in two  daily meals for seven days.
2.4. Sample collection and immunization assays
Before each sampling, the ﬁsh were starved for 18-24 h, and after each experimental period, all of the remaining ﬁsh
were sampled, anesthetized and individually weighed and measured to evaluate their growth performance in terms of their
weight (g), length (cm), feed intake (g). To evaluate the ﬁrst trial after seven and 15 days of feeding, two ﬁsh from each
tank (12 ﬁsh per treatment) were anesthetized (with benzocaine in ethanol, 0.1 g/L) and weighed and measured; their blood
was then collected from the caudal vasculature. After a whole blood sample was obtained for hematological assays and
for determining leukocyte burst activity, the blood was allowed to clot, and the serum was  separated by centrifugation
(3,000 × g for 5 min). The serum was stored at −80 ◦C until further analysis. After this procedure, the livers of the sampled
ﬁsh were weighed to determine their hepatosomatic index (HSI) as calculated by taking the ratio of the liver weight and the
total weight multiplied by 100.
To evaluate the second trial after seven days, two  ﬁsh from each tank for each treatment (12 ﬁsh per treatment) were
anesthetized (in benzocaine in ethanol, 0.1 g/L) and subjected to the same sample collection procedure. The remaining ﬁsh
from all treatments were immunized with 1 mL  of 1 × 109 CFU of A. hydrophila that were inactivated by 3% formalin or with
phosphate-buffered saline (PBS). The strain (GenBank identiﬁcation as ATCC 7966-http://www.ncbi.nlm.nih.gov/genbank/)
was provided by the Laboratório de Patologia de Organismos Aquáticos(LAPOA-CAUNESP-Jaboticabal).  Following immu-
nization, the ﬁsh remained in their tanks for up to 15 days, and they were fed a levamisole-free commercial diet (28%
CP, 12.56 MJ/kgDE). After this period, two ﬁsh from each tank (12 ﬁsh per treatment) were anesthetized with benzocaine
(0.1 g/L), and blood was drawn for serum extraction. The serum was stored at −80 ◦C prior to determining the titer of serum
agglutinating antibodies against A. hydrophila.
2.5. Innate immunity and serum biochemical and hematological parameters
The evaluation of the serum bactericidal activity of pacu against A. hydrophila was performed according to the methodol-
ogy recommended by Kajita et al. (1990) and Aly et al. (2008), with some modiﬁcations (Biller-Takahashi et al., 2013). In brief,
to evaluate the serum bactericidal activity, serum samples were mixed at a 1:1 ratio with A. hydrophila at a concentration of
1 × 108 CFU/mL and incubated for 90 min  at 25 ◦C. A positive control containing only the bacterial suspension in buffer was
incubated under the same conditions. The numbers of viable bacteria were then calculated by counting the CFUs from the
resulting incubated suspension on duplicate TSA plates after 24 h. The bactericidal activity of the test sera was  expressed as
the CFU values in the test and control groups.
The lysozyme activity level was measured by turbidimetric assay as described by Ellis (1990). Lyophilized hen egg white
lysozyme (SIGMA, St. Louis, MO,  USA) was used to develop a standard curve. A 20 mg  solution of Micrococcus lysodeikticus
(SIGMA, St. Louis, MO,  USA) in 100 mL  of sodium phosphate buffer (0.05 M,  pH 6.2) was used. The assay was initiated in a
microplate at a dilution of 1:1 (50 L of phosphate buffer:50 L of serum), and twofold serial serum dilutions were prepared
by adding 50 L of diluted serum to the remaining wells, which were ﬁlled with 50 L of PBS. Then, 125 L of M. lysodeikticus
was added. The reaction was performed at 25 ◦C, and the absorbance was  measured at 450 nm after 0.5 and 5.0 min  with a
microplate reader (Benchmark, BIORAD, USA). The results were expressed in units of lysozyme per mL  of serum. One unit is
deﬁned as the amount of sample required to reduce the absorbance by 0.001/min at 450 nm compared with the control (M.
lysodeikticus suspension without serum).
The assay for the leukocyte respiratory burst activity was conducted according to Biller-Takahashi et al. (2013). Total
blood was collected from the caudal vessels of ﬁsh from each treatment, and 0.1 mL of heparinized blood was added to
0.1 mL  of 0.2% nitroblue tetrazolium (NBT, SIGMA, St Louis, MO,  USA). The solution was incubated for 30 min  at 25 ◦C. A
50 L volume of the resulting suspension was added to a glass tube containing 1.0 mL  of N,N-dimethylformamide (DMF,
SIGMA, St Louis, MO,  USA) and centrifuged at 2500 × g for 5 min. The optical density (OD) of the ﬁnal solution was  measured
at 540 nm.
Total serum protein concentrations were evaluated by the biuret method (Labtest Kit) (Reinhold, 1953), and the albumin
concentration was determined by colorimetric assay with bromocresol green binding (Labtest Kit) (Doumas et al., 1971).
The amount of globulin present in the samples was determined by subtracting the albumin from the total serum protein,
and the globulin-albumin index (A:G) was estimated by dividing the value of the albumin fraction by that of the globulin
fraction for each tested sample.The hematocrit, red blood cells, hemoglobin content and mean corpuscular volume were determined with heparinized
blood and an automatic counter (Celm CC550, Sao Paulo, Brazil) that was  standardized using the microhematocrit method
described by Brown (1988). The white blood cell count and differential leukocyte count were determined from blood smears
stained with May-Grünwald-Giemsa (Rosenfeld, 1947). The white blood cell number was calculated using the following
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Fig. 1. Serum bactericidal activity (mean ± SD) of Piaractus mesopotamicus that consumed levamisole for seven or 15 days. Uppercase letters denote
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tigniﬁcant differences among levamisole concentrations, and lowercase letters denote signiﬁcant differences between days of sampling (P = 0.0075).
ormula, as described by Ishikawa et al. (2008): leukocytes/L = (leukocyte number in the smear x erythrocyte
umber/L)/2000 erythrocytes counted in the smear.
.6. Determination of acquired immunity, titer of serum agglutinating antibodies
The acquired immunity was assessed with an agglutinating antibody titer by following the method described by Biller-
akahashi et al. (2013) with a 96-well microtiter plate with round-bottom wells. The assay was  initiated with a 1:1 dilution
f phosphate buffer:serum, and subsequent twofold serial serum dilutions were prepared by adding diluted serum to the
emaining PBS-ﬁlled wells. As a result, the serum dilutions were 1/2, 1/4, 1/8, 1/16, 1/32, 1/64, 1/128, 1/256, 1/512, 1/1024
nd 1/2048. An inactivated A. hydrophila suspension was  then added to each well. The microplates were covered with plastic
lm and incubated at room temperature for 16-18 h. The agglutination end point was established as the last serum dilution
n which agglutination was visible. Agglutination antibody titers were expressed as the log2 (x+1) of the reciprocal for the
ighest serum dilution that exhibited visible agglutination in comparison with the positive control. The last well was used
s a negative control and contained only PBS buffer.
.7. Statistical analysis
Data were analyzed with SAS (Statistical Analysis System, Version 9.2, Cary, NC, USA) in a complete randomized design.
he experimental unit considered here was the tank; for growth performance, the value corresponded to the average of
ll of the ﬁsh per tank, and for all of the other parameters, the values corresponded to two ﬁsh per tank. Two-way ANOVA
ests using Tukey’s multiple range test were used to compare means. Differences were considered statistically signiﬁcant at
 < 0.05.
. Results
.1. Feeding Trial 1
Serum bactericidal activity was increased in the three groups that were treated with levamisole, and the CFU values of the
reated groups were statistically equivalent (Fig. 1). The lysozyme activity was highest in the group that received 500 mg/kg
f levamisole for 15 days (Fig. 2). The leukocyte respiratory burst activity of the ﬁsh that consumed levamisole for seven
ays was high; however, no differences were observed among the concentrations (Table 1).
The total protein (average: 3.76 g/dL; P = 0.0551), albumin (average: 1.13 g/dL; P = 0.6458), serum globulin (average:
.65 g/dL; P = 0.1952) and A:G index (Table 1) values showed no differences between the groups that were treated with
evamisole and the control in Trial 1.
The hematological responses of the ﬁsh that consumed levamisole (Table 1), including the hematocrit and red blood cell
ount, were inﬂuenced by the concentration of immunostimulant. The ﬁsh that were given 500 mg/kg levamisole showed
igher hematocrit values in comparison with the other treated groups, and the red blood cell count was  higher in the ﬁsh
hat were given500 mg/kg of levamisole compared with the 250 mg/kg group.
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Fig. 2. Serum lysozyme activity (mean ± SD) from Piaractus mesopotamicus that consumed levamisole for seven or 15 days. Uppercase letters denote
signiﬁcant differences among levamisole concentrations, and lowercase letters denote signiﬁcant differences between days of sampling (P = 0.0089).
Table 1
Innate immunity, biochemical and hematological parameters of Piaractus mesopotamicus that consumed levamisole for seven or 15 days in Trial 1*.
Days Levamisole mg/kg Mean Pooled P-value
0 125 250 500 SEM L D L × D
Burst (OD) 7 0.23 0.18 0.20 0.25 0.21 A 0.01 0.5584 0.0034 0.4762
15  0.14 0.15 0.13 0.14 0.14 B
Mean 0.17 0.17 0.18 0.22
A:G index 7 0.41 0.46 0.43 0.58 0.47 0.02 0.1729 0.7600 0.8771
15  0.45 0.48 0.36 0.49 0.45
Mean 0.40 0.47 0.42 0.56
Hematocrit
(%)
7  29.2 26.8 29.2 31.0 29.3 B 0.87 0.0139 0.0005 0.2640
15  34.4 34.9 30.7 41.7 35.1 A
Mean 32.1 ab 28.8 b 36.4 a 30.3 ab
HGB (g/dl) 7 12.8 12.0 12.8 13.3 12.8 0.29 0.9047 0.5945 0.6876
15  13.7 13.5 13.0 13.0 13.1
Mean 13.3 12.7 12.9 13.2
MCV (ﬂ) 7 164 167 169 165 166 A 0.85 0.1014 0.0001 0.4770
15  156 157 161 163 159 B
Mean 160 162 165 164
RBC (×106/l) 7 2.95 2.74 2.86 3.08 2.95 0.05 0.0046 0.8161 0.0907
15  2.83 2.92 2.58 3.23 2.93
Mean 2.89 ab 2.87 b 2.83 b 3.20 a* Different uppercase letters denote signiﬁcant differences between the period of levamisole administration. Different lowercase letters denote signiﬁcant
differences among the treatments with different levamisole concentrations (P < 0.05). L. levamisole concentration; D. days of sampling; Burst. leukocyte
respiratory burst activity; A:G. albumin:globulin; HGB. hemoglobin; MCV. mean corpuscular volume; RBC. red blood cell; SEM. standard error of the mean.
3.2. Feeding Trial 2
The serum bactericidal activity (Fig. 3) and lysozyme concentration (Fig. 4) were higher after A. hydrophila inoculation.
The sera of ﬁsh that received 500 mg/kg of levamisole presented the greatest bactericidal activity both before and after
bacterial inoculation (Fig. 4) when compared with the groups receiving lower concentrations of levamisole. The leukocyte
respiratory burst activity (Table 2) was evaluated by reactive oxygen species (ROS) production and was  not inﬂuenced by
the immunostimulant or by A. hydrophila inoculation.
The biochemical parameters, such as the total protein (average: 3.80 g/dL; P = 0.4272), albumin (average: 1.29 g/dL;
P = 0.4846), and serum globulin (average: 2.45 g/dL; P = 0.2115) evaluated in pacu that received levamisole for seven days
and were inoculated with A. hydrophila were not different from those of ﬁsh in the control group, including the A:G index
(Table 2).
Levamisole administration and inoculation with A. hydrophila increased the number of red blood cells, and, consequently,
the hematocrit of the treated ﬁsh. The hemoglobin and MCV  values were not inﬂuenced by the immunostimulant or by
bacterial immunization, and there were no signiﬁcant differences among the treatments (Table 2).
The white blood cell, lymphocytes, SGC and thrombocytes were primarily elevated in the groups that were treated with
125 or 250 mg/kg of levamisole and after immunization. Inoculation under the inﬂuence of levamisole led to an increase in
the number of neutrophils and monocytes, except for the number of eosinophils (Table 3).
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Fig. 3. Serum bactericidal activity (mean ± SD) of Piaractus mesopotamicus before immunization, injected with PBS and after immunization. Uppercase
letters denote signiﬁcant differences among levamisole concentrations, and lowercase letters denote signiﬁcant differences between challenge periods
(P  = 0.0026).
Fig. 4. Serum lysozyme activity (mean ± SD) from Piaractus mesopotamicus fed levamisole and immunized with Aeromonas hydrophila. Bars marked with
different letters are signiﬁcantly different (P = 0.0034).
Table 2
Innate immunity, biochemical and hematological parameters of Piaractus mesopotamicus that consumed levamisole and immunized in Trial 2*.
Challenge Levamisole mg/kg Pooled P-value
0 125 250 500 SEM
Burst (OD) Before 0.23 0.18 0.20 0.25 1.89 0.1772
After  0.16 0.16 0.13 0.14
PBS 0.20 0.18 0.16 0.17
A:G  index Before 0.41 0.46 0.43 0.58 0.02 0.3976
After  0.49 0.49 0.56 0.53
PBS 0.42 0.46 0.62 0.52
Hematocrit
(%)
Before 29.2 Aa 26.8 Ab 29.2 Aa 32.0 Aab 0.73 0.0426
After  30.3 Ba 41.3 Aa 35.6 ABa 36.8 ABa
PBS  30.2 Aa 26.2 Ab 31.0 Aa 27.3 Ab
HGB  (g/dl) Before 12.8 12.02 12.83 13.7 0.25 0.5356
After  11.1 13.68 13.2 14.13
PBS 12.1 11.18 12.57 11.95
MCV  (fL) Before 164 167 169 165 0.73 0.1457
After  162 166 166 163
PBS 174 170 165 170
* Different uppercase letters denote signiﬁcant differences among the levamisole treatments. Different lowercase letters denote signiﬁcant differ-
ences  among the challenged groups (P < 0.05). PBS. phosphate-buffered saline; Burst. leukocyte respiratory burst activity; A:G. albumin:globulin; HGB.
hemoglobin; MCV. mean corpuscular volume.
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Table 3
Total and differential counts of blood cells from Piaractus mesopotamicus that consumed levamisole and immunized in Trial 2*.
Challenge Levamisole mg/kg Pooled P-value
0 125 250 500 SEM L C L × C
RBC (×106/l) Before 2.95 Aa 2.81 Ab 2.95 Aa 3.12 Aa 0.05 0.4676 0.001 0.0336
After  2.92 Ba 3.51 Aa 3.17 Aa 3.31 ABa
PBS 2.60 Aa 2.42 Ac 2.78 Aa 2.49 Ab
Thrombocytes
(×103/l)
Before 21.7 Aab 18.8 Ab 21.7 Ab 23.5 Aa 1.85 0.0112 0.0001 0.004
After 29.9 Ba 54.7 Aa 37.0 Aab 39.1 Aa
PBS 12.7 Bb 20.7 ABb 41.9 Aa 42.9 Aa
WBC  (×103/l) Before 26.0 Aa 20.3 Ab 21.5 Ab 28.3 Aa 1.99 0.0032 0.0001 0.0018
After 31.4 Ba 53.0 Aa 61.3 Aa 40.2 Ba
PBS  27.8 ABa 19.6 Bb 48.8 Aa 39.4 ABa
Lymphocytes
(×103/l)
Before 23.5 Aa 17.3Ab 19.1 Ab 25.7 Aa 1.72 0.0064 0.0001 0.001
After 24.6 Ba 43.2 ABa 55.2 Aa 30.9 Ba
PBS  24.0 Aa 16.6 Ab 37.0 Aa 34.4 Aa
Neutrophil
(×103/l)
Before 1.53 Aa 1.34 Ab 1.44 Ab 1.76 Aa 1.92 0.2321 0.0018 0.002
After  2.47 Aa 3.18 Aa 2.19 Aab 3.49 Aa
PBS 2.13 Aa 1.42 Ab 4.92 Aa 2.46 Aa
Eosinophil
(×103/l)
Before 0.18 0.64 0.45 0.34 0.39 0.3355 0.1676 0.7246
After 0.31 0.44 0.30 0.30
PBS  0.26 0.21 0.25 0.22
Monocytes
(×103/l)
Before 0.43 Ab 0.52 Ab 0.27 Ab 0.29 Ac 0.14 0.1673 0.0001 0.0001
After 0.98 Aa 2.58 Aa 1.95 Aa 2.80 Aa
PBS  1.05 Aa 0.63 Ab 1.44 Aab 1.54 Ab
SGC (×103/l) Before 0.35 Ab 0.44 Ab 0.23 Ab 0.29 Ab 0.26 0.1639 0.0004 0.006
After  2.05 Aa 3.57 Aa 1.65 Aa 2.70 Aa
PBS  0.31 Ab 0.73 Ab 0.51 Ab 0.79 Aab
* Different uppercase letters denote signiﬁcant differences among the levamisole treatments. Different lowercase letters denote signiﬁcant differences
among the challenged groups (P < 0.05). L. levamisole concentration; C. challenge; PBS. phosphate-buffered saline; RBC. red blood cell; WBC. White blood
cell;  SCG. special granulocytic cell; SEM. standard error of the mean.Fig. 5. Serum agglutinating antibodies titers (mean ± SD) against Aeromonas hydrophila in immunized Piaractus mesopotamicus that consumed levamisole
for  seven days. Bars marked with different letters are signiﬁcantly different (P < 0.0001).
Dietary levamisole supplementation at 125 or 250 mg/kg for seven days and immunization with A. hydrophila increased
the agglutinating antibody titer (Fig. 5).
There were no mortalities during the experimental period, and there were no differences in the growth performance or
hepatosomatic index (HSI) among the treatments (Table 4).
4. Discussion
The primary result of the current study is that levamisole may  be administered through the diet to promote an adjuvant
effect on the immunity of pacu (Piaractus mesopotamicus), primarily at 125 or 250 mg/kg.
Seven days of levamisole treatment improved the values for the leukocyte respiratory burst activity, with increased pro-
duction of ROS, which is a known indicator of early protection that destroys pathogens and defends the body against potential
infections. Therefore, an increase in this parameter can be a sign of enhanced resistance to infection and a strengthened
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Table  4
Growth performance parameters of Piaractus mesopotamicus that consumed levamisole.
Days Levamisole (mg/kg) Pooled P-value
0 125 250 500 SEM
Weight (g) 7 182 187 211 193 0.90 0.3223
15  199 204 228 208
Length (cm) 7 20.5 19.9 21.7 21.1 0.02 0.1295
15  21.4 21.3 22.0 21.4
Feed intake (g) 7 34.3 33.7 34.2 34.1 0.38 0.2731
15  76.5 77.7 79.8 78.1
HSI 7  1.56 1.65 1.62 1.31 0.04 0.3991
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SI, hepatosomatic index; SEM, standard error of the mean.
mmune system (Biller-Takahashi et al., 2013; Guimarães et al., 2014). Similar results were observed by Kumari and Sahoo
2006) in Clarias batrachus supplemented with 50 mg/kg of levamisole for 10 days; however, the highest levels of oxidative
adical production were found after three weeks, and the greatest increase in the concentration of serum myeloperoxidase
as observed after two weeks.
Furthermore, the shortest period of levamisole administration increased the ability to respond and increased the energy
emand through the release of young red blood cells, the erythroblasts, as indirectly observed by the increased MCV  (Houston
nd Murrad, 1992). Conversely, pacu that received levamisole for 15 days were able to face some immunological challenge
ecause of their increased hematocrit and lysozyme activity, once lysozyme is present in the mucus, eggs, blood and tissues,
n which leukocytes, primarily neutrophils and monocytes, can be found to combat the pathogen (Secombes, 1996; Tort,
011).
Because of these ﬁndings, the ﬁrst feeding trial provided important information about the effectiveness of levamisole
n the innate immune system of pacu, and these data could be important for future studies involving feeding protocols for
mmunostimulation. There was also a lack of improvement in growth performance after seven or 15 days of feeding, and
hus the shortest treatment period was chosen to assess Trial 2. It is sensible to identify the shortest period required for
mmunomodulation to avoid overstimulating the immune system and the appearance of a trade-off with other physiological
echanisms, such as growth performance or reproduction as well as to reduce needless costs.
The responses in Trial 2 were conclusive, and the inﬂuence of the immunostimulant was more evident at 125 or 250 mg/kg
f dietary levamisole. The combined effect of immunization and levamisole administration resulted in increased lytic pro-
eins, as assessed by serum bactericidal activity, indicating an ability to destroy bacteria through pathogen cell lyses. Similar
esults were described by Kumari and Sahoo (2006) in C. batrachus that received 50, 150 or 450 mg/kg of levamisole for 10
ays. In addition, immunization was an important practice because of the effectiveness of the responses compared with Trial
, and because of the increased lysozyme activity, which was found primarily after immunization. This ability showed poten-
ial activity against gram-positive and some gram-negative bacteria, and lytic proteins and lysozyme are very well-known
ools for protecting the host organism (Alexander and Ingram, 1992; Guimarães et al., 2014).
However, in our study, levamisole and A. hydrophila inoculation did not inﬂuence leukocyte respiratory burst activity, as
easured by the assay for evaluating the production of ROS after phagocytosis, even though the administration of levamisole
n Trial 1 did signiﬁcantly increase this parameter, showing that the efﬁciency of immune modulation is related to the
reatment period, dose and administration route as well as the age, immune status and interspecies variations of the ﬁsh
Mulero et al., 1998; Sink and Lochmann, 2014).
The observation of effective results depends on many factors as described above, and with regards to hematological
arameters, it was possible to establish that the administration of 125 or 500 mg/kg of levamisole after bacterial inoculation
as able to modulate the erythropoietic organs and increase the number of red blood cells, and, therefore, the hematocrit.
he treatment increased competent immune cells, which can lead to lytic protein production by these cells, as assessed by
acu serum bactericidal activity and lysozyme activity (Soltani and Kalbassi, 2001).
Even after inoculation with the infectious agent, the hemoglobin and MCV  values of the ﬁsh in this study remained
onstant; however, it may  be considered a positive effect of the immunostimulant because hematopoietic parameters are
sually elevated under stress, as caused by the pathogen inoculation in this study, to provide energy to overcome stressful
onditions (Tort, 2011).
Dietary levamisole likely triggered cell proliferation in pacu by increasing the number of T lymphocytes, as indirectly
bserved by the elevated hematocrit (Renoux, 1980), and also because of the augmented white blood cell, lymphocyte and
CG counts that were primarily observed at 125 or 250 mg/kg of the immunostimulant, which inﬂuenced the acquired
esponse. The evaluation of the circulating leukocytes number was important to assess the ROS production, primarily by
onsidering the amounts of neutrophils and monocytes because these cells are potent ROS producers. However, because
he populations of these cells were similar among the treatments and the control, the results also showed no signiﬁcant
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differences in ROS as assessed by leukocyte respiratory burst activity (Biller-Takahashi et al. 2013). Moreover, the lack of
leukocyte respiratory burst activity likely occurred to limit the production of ROS by the defense system to avoid an excess
of these compounds and their consequent oxidative stress, as observed by Biller-Takahashi et al. (2015).
Regarding acquired responses, the bacterial inoculation and administration of levamisole for seven days, primarily at
125 and 250 mg/kg, increased the activity of defense cells and antibody titers against A. hydrophila. This result indicated
that levamisole prompted an adjuvant effect by enhancing the intensity of the innate and acquired immune response, even
when administered through the diet. This ﬁnding is essential for future studies about feed protocols for immunization, and it
represents an additional advantage in that dietary administration is considered to be a non-invasive method for promoting
immunostimulation.
Studies in other ﬁsh species also demonstrate the efﬁciency of immunization in conjunction with levamisole administra-
tion because this compound shows adjuvant effects. Jeney and Anderson (1993) observed increases in several parameters
of the innate and acquired immune systems in rainbow trout that result in greater protection against A. salmonicida. Cuesta
et al. (2004) found that IgM concentrations increased in Sparus aurata after two weeks of levamisole administration and
that the effect persisted for more than six weeks. Therefore, this immunostimulant may  be administered before vaccination
because this compound shows adjuvant effects even when administered through the diet.
Some research has indicated that the phagocytosis of invading agents and the production of antibodies are modulated
by the amount of competent immune cells (Tempero et al., 1995; Guimarães et al., 2014). Such responses were observed by
Singh et al. (2010) in C. carpio that were given 250 mg/kg of levamisole and challenged with A. hydrophila.  Similar results
were also demonstrated by Khoshbavar-Rostami et al. (2007), who observed an increase in competent immune cells after
inoculation with A. hydrophila in Huso huso. Pacu that were given 125 or 250 mg/kg of levamisole and immunized showed
increased lymphocytes values and a consequently increased antibody titer.
Immunization itself is a powerful trigger of the immune system and has an improved effect when combined with a
compound such as levamisole, as observed in this study, because this immunostimulant is a T-independent antigen that
demonstrably enhances the acquired response by modulating natural killer cells to mediate cell lysis and MHC  receptor
expression. Levamisole also induces the production of inﬂammatory cytokines, such as IFN- and IL-6, which are important
for boosting immunological responses (Holcombe et al., 2006; Kang et al., 2005).
The search for alternative feeds with the addition or substitution of components is a current line of research that has
been widely applied; however, many factors such as the dose and time of administration are important for determining
the response (Henry et al., 2015; Kiron, 2012; Sakai, 1999). In conclusion, administering levamisole for seven days (125
or 250 mg/kg) and immunizing pacu have beneﬁcial effects on immune and hematological parameters and signiﬁcantly
increase antibody titers against A. hydrophila,  indicating that this immunostimulant may  be used as a vaccination adjuvant
to improve immunity, even in the diet, constituting a strategy for a feed protocol prior to immunization. In addition to
modulating the immune system through the use of immunization and immunostimulants as an alternative to the use of
antibiotics, further studies focusing on other protocols should be performed to explore the effects of levamisole on the innate
immunity of this species of great economic interest.
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